COM:REGULUSRX
Regulus Therapeutics
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.regulusrx.com/ipo date
Oct 09, 2012
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8...Show More